CA2581240A1 - Rhd and abo genotyping by multiplex pcr - Google Patents
Rhd and abo genotyping by multiplex pcr Download PDFInfo
- Publication number
- CA2581240A1 CA2581240A1 CA002581240A CA2581240A CA2581240A1 CA 2581240 A1 CA2581240 A1 CA 2581240A1 CA 002581240 A CA002581240 A CA 002581240A CA 2581240 A CA2581240 A CA 2581240A CA 2581240 A1 CA2581240 A1 CA 2581240A1
- Authority
- CA
- Canada
- Prior art keywords
- rhd
- nucleic acids
- abo
- gene
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000007403 mPCR Methods 0.000 title claims description 27
- 238000003205 genotyping method Methods 0.000 title claims description 26
- 238000000034 method Methods 0.000 claims description 109
- 239000008280 blood Substances 0.000 claims description 77
- 210000004369 blood Anatomy 0.000 claims description 76
- 108020004707 nucleic acids Proteins 0.000 claims description 71
- 102000039446 nucleic acids Human genes 0.000 claims description 71
- 150000007523 nucleic acids Chemical class 0.000 claims description 71
- 102100027544 Blood group Rh(D) polypeptide Human genes 0.000 claims description 68
- 101150108975 Rhd gene Proteins 0.000 claims description 53
- 101150099178 abo gene Proteins 0.000 claims description 49
- 108090000623 proteins and genes Proteins 0.000 claims description 41
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 108020004414 DNA Proteins 0.000 claims description 26
- 238000004458 analytical method Methods 0.000 claims description 25
- 108700024394 Exon Proteins 0.000 claims description 17
- 238000000137 annealing Methods 0.000 claims description 13
- 101100011399 Danio rerio eif3ea gene Proteins 0.000 claims description 9
- 102000008016 Eukaryotic Initiation Factor-3 Human genes 0.000 claims description 9
- 101150008815 INT6 gene Proteins 0.000 claims description 9
- 239000000523 sample Substances 0.000 claims description 8
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 6
- 239000002853 nucleic acid probe Substances 0.000 claims description 6
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 claims description 3
- 108010056664 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 claims description 3
- 102100035893 CD151 antigen Human genes 0.000 claims description 2
- 101000946874 Homo sapiens CD151 antigen Proteins 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims 1
- 230000003321 amplification Effects 0.000 abstract description 22
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 22
- 238000003752 polymerase chain reaction Methods 0.000 description 51
- 108700028369 Alleles Proteins 0.000 description 20
- 239000002773 nucleotide Substances 0.000 description 17
- 125000003729 nucleotide group Chemical group 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- 102100038341 Blood group Rh(CE) polypeptide Human genes 0.000 description 15
- 101000666610 Homo sapiens Blood group Rh(CE) polypeptide Proteins 0.000 description 15
- 239000000427 antigen Substances 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 101100446506 Mus musculus Fgf3 gene Proteins 0.000 description 8
- 101100317378 Mus musculus Wnt3 gene Proteins 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 230000004544 DNA amplification Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000001502 gel electrophoresis Methods 0.000 description 6
- 230000035772 mutation Effects 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000005755 formation reaction Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 230000000405 serological effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010060935 Alloimmunisation Diseases 0.000 description 4
- 108091093088 Amplicon Proteins 0.000 description 4
- 108700023372 Glycosyltransferases Proteins 0.000 description 4
- 239000000539 dimer Substances 0.000 description 4
- 102000051366 Glycosyltransferases Human genes 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 208000003441 Transfusion reaction Diseases 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 102000054765 polymorphisms of proteins Human genes 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- RXZBMPWDPOLZGW-HEWSMUCTSA-N (Z)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N\OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-HEWSMUCTSA-N 0.000 description 1
- 101150098072 20 gene Proteins 0.000 description 1
- 101710157236 41 kDa protein Proteins 0.000 description 1
- 101150096316 5 gene Proteins 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 108091023043 Alu Element Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 230000010558 Gene Alterations Effects 0.000 description 1
- 206010067122 Haemolytic transfusion reaction Diseases 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 101150014174 calm gene Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 101150088365 intG gene Proteins 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 102220001065 rs121918296 Human genes 0.000 description 1
- 101150041393 rsd gene Proteins 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0421136A GB0421136D0 (en) | 2004-09-22 | 2004-09-22 | Sequences |
| GB0421136.3 | 2004-09-22 | ||
| GB0505983A GB0505983D0 (en) | 2005-03-23 | 2005-03-23 | Gene analysis |
| GB0505983.7 | 2005-03-23 | ||
| PCT/GB2005/003659 WO2006032897A2 (en) | 2004-09-22 | 2005-09-22 | Rhd and abo genotyping by multiplex pcr |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2581240A1 true CA2581240A1 (en) | 2006-03-30 |
Family
ID=35998457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002581240A Abandoned CA2581240A1 (en) | 2004-09-22 | 2005-09-22 | Rhd and abo genotyping by multiplex pcr |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090186340A1 (enExample) |
| EP (1) | EP1802767A2 (enExample) |
| JP (1) | JP2008513036A (enExample) |
| CA (1) | CA2581240A1 (enExample) |
| ES (1) | ES2302667T1 (enExample) |
| WO (1) | WO2006032897A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1591534A1 (en) | 2004-04-01 | 2005-11-02 | Stichting Sanquin Bloedvoorziening | A method of genotyping blood cell antigens and a kit suitable for genotyping blood cell antigens |
| AU2008213634B2 (en) * | 2007-02-08 | 2013-09-05 | Sequenom, Inc. | Nucleic acid-based tests for RhD typing, gender determination and nucleic acid quantification |
| WO2009130797A1 (ja) * | 2008-04-22 | 2009-10-29 | 東洋鋼鈑株式会社 | Abo式血液型を判定するためのプローブセット |
| US20110070590A1 (en) | 2009-09-22 | 2011-03-24 | Jan Rohozinski | Primers and Methods for Determining RhD Zygosity |
| GB201008125D0 (en) * | 2010-05-14 | 2010-06-30 | Biofortuna Ltd | Tissue typing assays and kits |
| EP2471949B1 (en) * | 2010-12-31 | 2013-12-25 | Progenika Biopharma, S.A. | Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W) |
| EP2721171A1 (en) * | 2011-06-17 | 2014-04-23 | Progenika Biopharma, S.A. | Discrimination of blood type variants |
| US20160010153A1 (en) * | 2013-03-15 | 2016-01-14 | Life Technologies Corporation | Novel compositions, methods and kits for blood typing |
| CN103361422B (zh) * | 2013-05-24 | 2014-12-17 | 浙江工商大学 | 一种鉴别掺假肉及其制品的多重pcr快速检测方法 |
| CN112029842B (zh) * | 2020-08-31 | 2021-04-27 | 深圳市血液中心(深圳市输血医学研究所) | 一种基于高通量测序进行abo血型基因分型的试剂盒和方法 |
| CN118291605A (zh) * | 2024-04-10 | 2024-07-05 | 深圳市血液中心(深圳市输血医学研究所) | 一种基于ngs的多系统红细胞血型基因分型方法和试剂盒 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5882856A (en) * | 1995-06-07 | 1999-03-16 | Genzyme Corporation | Universal primer sequence for multiplex DNA amplification |
| US6265557B1 (en) * | 1997-05-09 | 2001-07-24 | Loma Linda University Medical Center | ABO histo-blood group O alleles of the baboon |
| ES2241195T3 (es) * | 1998-01-23 | 2005-10-16 | Drk Blutspendedienst Baden-Wurttemberg Ggmbh | Nuevas moleculas de acidos nucleicos correlacionadas con el fenotipo debil d rhesus. |
| AU2001242507A1 (en) * | 2000-04-20 | 2001-11-07 | Adnagen Ag | Method, diagnostic kit and microarray for determining the rhesus factor |
| EP1591534A1 (en) * | 2004-04-01 | 2005-11-02 | Stichting Sanquin Bloedvoorziening | A method of genotyping blood cell antigens and a kit suitable for genotyping blood cell antigens |
-
2005
- 2005-09-22 WO PCT/GB2005/003659 patent/WO2006032897A2/en not_active Ceased
- 2005-09-22 CA CA002581240A patent/CA2581240A1/en not_active Abandoned
- 2005-09-22 EP EP05786348A patent/EP1802767A2/en not_active Withdrawn
- 2005-09-22 US US11/663,624 patent/US20090186340A1/en not_active Abandoned
- 2005-09-22 JP JP2007532957A patent/JP2008513036A/ja active Pending
- 2005-09-22 ES ES05786348T patent/ES2302667T1/es active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20090186340A1 (en) | 2009-07-23 |
| WO2006032897A3 (en) | 2006-09-28 |
| JP2008513036A (ja) | 2008-05-01 |
| EP1802767A2 (en) | 2007-07-04 |
| ES2302667T1 (es) | 2008-08-01 |
| WO2006032897A2 (en) | 2006-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saiki et al. | Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes | |
| Yip | Single-tube multiplex PCR-SSCP analysis distinguishes 7 common ABO alleles and readily identifies new alleles | |
| Cavanagh et al. | HPA genotyping by PCR sequence‐specific priming (PCR–SSP): a streamlined method for rapid routine investigations | |
| CA2677517C (en) | Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification | |
| Lan et al. | Genetic polymorphism of RhD-negative associated haplotypes in the Chinese | |
| US5658764A (en) | Method and kits for detection of fragile X specific, GC-rich DNA sequences | |
| EP3219814A1 (en) | Probe for detection of polymorphism in egfr gene, amplification primer, and use thereof | |
| Moussa et al. | Molecular background of D‐negative phenotype in the Tunisian population | |
| Randen et al. | Rapid and reliable genotyping of human platelet antigen (HPA)‐1,‐2,‐3,‐4, and‐5 a/b and Gov a/b by melting curve analysis | |
| Rearden et al. | Glycophorin B and glycophorin E genes arose from the glycophorin A ancestral gene via two duplications during primate evolution. | |
| Di Cristofaro et al. | Single PCR multiplex SNaPshot reaction for detection of eleven blood group nucleotide polymorphisms: optimization, validation, and one year of routine clinical use | |
| CA2581240A1 (en) | Rhd and abo genotyping by multiplex pcr | |
| US9637788B2 (en) | Discrimination of blood type variants | |
| Denomme et al. | Molecular protocols in transfusion medicine | |
| Silvy et al. | Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles | |
| US8021845B2 (en) | Probes for detecting obesity gene | |
| Tanaka et al. | High-resolution melting analysis for genotyping Duffy, Kidd and Diego blood group antigens | |
| Castilho et al. | High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD | |
| US20090104612A1 (en) | Detection of blood group genes | |
| EP2471949B1 (en) | Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W) | |
| EP2584036B1 (en) | Probes for identifying SULT1A1 gene polymorphisms, probe sets and reagents containing the same, and the uses thereof | |
| Schrijver et al. | Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population | |
| EP1848821B1 (en) | Polynucleotide associated with breast cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing breast cancer using the same | |
| Zahari et al. | A nested allele-specific multiplex polymerase chain reaction method for the detection of DRD2 polymorphisms | |
| Ahmed | An approach for the prevention of thalassaemia in Pakistan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20131015 |